• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Special Reports
  • Technologies
    • Artificial Intelligence (AI)
    • Cardiovascular
    • Orthopedics
    • Neurological
    • Diabetes
    • Surgical Robotics
  • Business & Finance
    • Wall Street Beat
    • Earnings Reports
    • Funding Roundup
    • Mergers & Acquisitions
    • Initial Public Offering (IPO)
    • Legal News
    • Personnel Moves
    • Medtech 100 Stock Index
  • Regulatory
    • Food & Drug Administration (FDA)
    • Recalls
    • 510(k)
    • Pre-Market Approval (PMA)
    • MDSAP
    • Clinical Trials
  • Resources
    • About MassDevice
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech100 Index
    • Videos
    • Webinars
    • Whitepapers
    • Voices
    • In-Depth Coverage
    • Latest News
  • Attend DeviceTalks
    • Events
      • DeviceTalks Minnesota – May 4
      • DeviceTalks Boston – May 27–28
      • DeviceTalks West
      • DeviceTalks Tuesdays
    • DeviceTalks Podcast Network
      • DeviceTalks Weekly
      • AbbottTalks
      • Boston ScientificTalks
      • DeviceTalks AI
      • IntuitiveTalks
      • MedtechWOMEN Talks
      • MedtronicTalks
      • Neuro Innovation Talks
      • Ortho Innovation Talks
      • Structural Heart Talks
      • StrykerTalks
  • Advertise
  • Subscribe
Home » Pixee Medical wins CE mark for augmented reality knee surgery tech

Pixee Medical wins CE mark for augmented reality knee surgery tech

March 24, 2026 By Sean Whooley

Pixee Medical Knee+ NexSight
The Knee+ NexSight AR-powered surgical system in use. [Image courtesy of Pixee Medical]
Pixee Medical announced today that it received CE mark approval for Knee+ NexSight, with the first cases already performed in Europe.

Besançon, France-based Pixee designed its augmented reality (AR)-based solution for total knee arthroplasty. It already reports more than 20 procedures performed across France and Belgium by six surgeons. With CE mark in hand, the company now awaits the FDA’s review of a 510(k) clearance submission in the U.S.

The company already brought its previous-generation Knee NexSight system to the U.S., announcing the first U.S. procedure in May 2025. It had just unveiled the technology at AAOS in March 2025.

“Knee+ NexSight is not just an incremental update; it is a new way to think about AR guidance in high-volume environments,” said Sébastien Henry, CEO of Pixee Medical. “It brings the accuracy of a robot in the form factor of a pair of glasses – without heavy infrastructure, without pre-operative imaging, and without disposables. We now look forward to FDA clearance so we can support the first procedures in the United States and expand access to this technology.”

More about the latest technology from Pixee Medical

Pixee designed its Knee+ NexSight to meet the evolving needs of surgeons and the realities of high-throughput operating rooms. It projects a virtual screen directly onto the surgeon’s field of view and incorporates voice command to enhance user experience.

The new solution comes in lighter and more compact than the previous generation. It also requires no robot, no dedicated console and no single-use disposables. This aims to reduce capital investment, lower operating costs and minimize environmental impact.

Pixee says the platform delivers robotic-level accuracy while preserving. efficiency, cost-effectiveness and simplicity. It offers less invasive instrumentation to reduce blood loss while integrating seamlessly into existing surgical workflows, the company says.

Knee+ NexSight has full compatibility with most primary knee implants and supports personalized alignment strategies. That includes kinematic alignment. The platform’s software architecture also enables connectivity to deliver secure integration with third-party digital solutions. Remote software updates also come into play as operating rooms become increasingly data-driven, Pixee, said.

Filed Under: Artificial Intelligence (AI), Digital Health, Health Technology, Machine Learning (ML), Regulatory/Compliance, Software / IT, Surgical Tagged With: Pixee Medical

More recent news

  • Biotronik to acquire spinal cord stim tech from Soin Neuroscience
  • Vicarious Surgical’s board wants to shut down and liquidate robotics developer
  • Fractyl reports most GLP-1 weight loss maintained after single catheter treatment
  • Smith+Nephew unveils Lynx Coblation laryngeal wand
  • Glucotrack combines with Lōkahi Therapeutics to become CBGM subsidiary
Image

About Sean Whooley

Sean Whooley is a senior editor who mainly produces work for MassDevice, Medical Design & Outsourcing and Drug Delivery Business News. He received a bachelor's degree in multiplatform journalism from the University of Maryland, College Park. You can connect with him on LinkedIn or email him at [email protected].

Primary Sidebar

Cart

“md
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest med device regulatory, business and technology news.

DeviceTalks Weekly

See More >
MDO ad
MDO ad

Footer

Image

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World
Medical Design Sourcing

DeviceTalks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our DeviceTalks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us

Copyright © 2026 · Arrowfly LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of Arrowfly.

Privacy Policy